share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4:持股变动声明-高管 Gibson Christopher
美股sec公告 ·  07/12 18:58
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock on July 10 and July 11, 2024. Gibson sold a total of 75,000 shares through open market or private sales at prices ranging from $7.47 to $7.48 per share, resulting in a total market value of $747,500. Additionally, Gibson reported acquiring 100,000 shares at no cost, which is typically indicative of stock grants. After these transactions, Gibson's direct holdings in Recursion Pharmaceuticals amounted to 758,738 shares. The transactions were reported as completed and were conducted over a two-day period.
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock on July 10 and July 11, 2024. Gibson sold a total of 75,000 shares through open market or private sales at prices ranging from $7.47 to $7.48 per share, resulting in a total market value of $747,500. Additionally, Gibson reported acquiring 100,000 shares at no cost, which is typically indicative of stock grants. After these transactions, Gibson's direct holdings in Recursion Pharmaceuticals amounted to 758,738 shares. The transactions were reported as completed and were conducted over a two-day period.
2024年7月10日和11日,Recursion Pharmaceuticals的首席执行官Christopher Gibson完成了一系列公司A类普通股的交易。Gibson通过公开市场或私人销售以每股7.47美元至7.48美元的价格总计出售了75,000股,市值总计为747,500美元。此外,Gibson报告称获得了100,000股免费股票,这通常是股票授予的标志。在这些交易之后,Gibson在Recursion Pharmaceuticals的直接持股总数为758,738股。这些交易已经完成,并在两天的时间内进行。
2024年7月10日和11日,Recursion Pharmaceuticals的首席执行官Christopher Gibson完成了一系列公司A类普通股的交易。Gibson通过公开市场或私人销售以每股7.47美元至7.48美元的价格总计出售了75,000股,市值总计为747,500美元。此外,Gibson报告称获得了100,000股免费股票,这通常是股票授予的标志。在这些交易之后,Gibson在Recursion Pharmaceuticals的直接持股总数为758,738股。这些交易已经完成,并在两天的时间内进行。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息